SAR - Deltex Medical Group

RNS Number:0487S
Close Brothers Group PLC
13 November 2003


                                                                      FORM SAR 5

Lodge with a RIS or Newstrack and the Takeover Panel. A copy must also be sent
to the company the shares of which are sold.

                                            Date of disclosure: 12 November 2003

DISCLOSURE UNDER NOTE 3 ON RULE 5 OF THE RULES GOVERNING   SUBSTANTIAL
ACQUISITIONS  OF  SHARES  ("SARs")


Date of sale: 10 November 2003

Sale of:  Deltex Medical Group plc (name of company)

(1)Class of              Number of shares/            If rights over shares sold, 
   voting shares         rights over shares           as opposed to the shares  
   (eg ordinary          sold                         themselves,specify nature 
   shares)                                            of rights
   

   Ordinary              570,000 shares               
                         
                         rights                       N/A
                 


(2)Resultant total       Resultant total holding      Total
   holding of voting     of rights over shares        percentage
   shares (and % of      (and % of total voting 
   total voting shares   shares in issue)
   in issue)


   10,690,501 (17.32%)   (   %)                       17.32%
                                   
                                                                         

(3)  Party making disclosure: Close Brothers Group plc


(4)  (a)  Name of person selling shares or rights over shares:

            Close Brothers Investment Limited
            Close Investment Limited


            and, if different, beneficial owner


      (b)  Names of any other persons acting by
           agreement or understanding:


Signed, for and on behalf of the party named in (3) above


(Also print name of signatory): W J Jenkins


Telephone and extension number: 020 7426 4013


                     ______________________________________


For full details of the SARs disclosure requirements, see Rules 3 and 5 of the
SARs. If in doubt, contact the Panel on Takeovers and Mergers, Monitoring
Section, Tel. No: 020 7638 0129.
E-mail: [e-mail]


                                                                      FORM SAR 5

Lodge with a RIS or Newstrack and the Takeover Panel. A copy must also be sent
to the company the shares of which are sold.

                                            Date of disclosure: 12 November 2003

DISCLOSURE UNDER NOTE 3 ON RULE 5 OF THE RULES GOVERNING   SUBSTANTIAL
ACQUISITIONS  OF  SHARES  ("SARs")


Date of sale:  3 November 2003

Sale of:  Deltex Medical Group plc (name of company)


(1)Class of              Number of shares/            If rights over shares sold, 
   voting shares         rights over shares           as opposed to the shares  
   (eg ordinary          sold                         themselves,specify nature 
   shares)                                            of rights


   Ordinary              300,000 shares               
                                                                         
                         rights                       N/A



(2)Resultant total       Resultant total holding      Total
   holding of voting     of rights over shares        percentage
   shares (and % of      (and % of total voting 
   total voting shares   shares in issue)
   in issue)



   11,460,499 (18.57%)   (   %)                        18.57%



(3)  Party making disclosure: Close Brothers Group plc


(4)  (a)  Name of person selling shares or rights over shares:

            Close Investment Limited


            and, if different, beneficial owner


      (b)  Names of any other persons acting by
           agreement or understanding:


Signed, for and on behalf of the party named in (3) above


(Also print name of signatory): W J Jenkins


Telephone and extension number: 020 7426 4013


                     ______________________________________


For full details of the SARs disclosure requirements, see Rules 3 and 5 of the
SARs. If in doubt, contact the Panel on Takeovers and Mergers, Monitoring
Section, Tel. No: 020 7638 0129.
E-mail: [e-mail]








                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
SADILFVELALVLIV